Skip to main content
. 2017 Oct 16;8(55):94726–94737. doi: 10.18632/oncotarget.21886

Figure 1. Cordycepin (Cpn) inhibits atherosclerotic lesion formation.

Figure 1

(A) Representative image of the whole aorta. Bar = 1 mm. (B) Quantitation of atherosclerotic lesions in the whole aorta. (C) Serum lipids and glucose. (D) Hepatic levels of TC and TG. (E) Serum levels of pro-inflammatory factors. Values are means ± SEM (n = 8). ##p < 0.01, ###p < 0.001, vehicle vs. normal, *p < 0.05, **p < 0.01, ***p < 0.001, test group vs. vehicle group. TC, total cholesterol; TG, triglycerides; LDL-c, low-density lipoprotein cholesterol; HDL-c, high-density lipoprotein cholesterol; MCP-1, monocyte chemotactic protein-1; TNFα, tumor necrosis factor α; IL-6, interleukin-6.